COL18A1 and cancer: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and/or endostatin genes were delivered by nanoparticles to treat CC and were verified to offer considerable potential as an ideal candidate for cancer gene delivery therapy in vivo (80).